Your Article Summary
See Latest ArticlesBranch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C
World Journal of Gastroenterology, 08/16/06
Goncalves LL, et al. - Ophthalmological complications with interferon therapy are usually mild and reversible, not requiring the withdrawal of the treatment. We report a case of a patient who had visual loss probably associated with interferon therapy. Chronic hepatitis C virus infection (genotype 1a) was diagnosed in a 33-year old asymptomatic man
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Taking the stress out of managing gout
Canadian Family Physician, 12/17/09
Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression
Anesthesiology, 12/17/09
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Role of transcatheter arterial embolization for massive bleeding from gastroduodenal ulcers
World Journal of Gastroenterology, 12/17/09
Anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases
Alimentary Pharmacology and Therapeutics, 12/17/09